|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4,4'-Methylenebis(2-chloroaniline) | CAS 101-14-4 | ||
| CH2(C6H4ClNH2)2 | RTECS CY1050000 | ||
|
Synonyms & Trade Names DACPM; 3,3'-Dichloro-4,4'-diaminodiphenylmethane; MBOCA; 4,4'-Methylenebis(o-chloro aniline); 4,4'-Methylenebis(2-chlorobenzenamine); MOCA |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: Ca TWA 0.003 mg/m3 [skin] See Appendix A | ||
| OSHA PEL�: none | |||
| IDLH Ca [N.D.] | Conversion | ||
|
Physical Description Tan-colored pellets or flakes with a faint, amine-like odor. |
|||
|
MW: 267.2 |
BP: ? |
MLT: 230°F |
Sol: Slight |
|
VP(77°F): 0.00001 mmHg |
IP: ? |
|
Sp.Gr: 1.44 |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
|
Incompatibilities & Reactivities Chemically-active metals (e.g., potassium, sodium, magnesium, zinc) |
|||
|
Measurement Methods OSHA 24, 71 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Hematuria (blood in the urine), cyanosis, nausea, methemoglobinemia, kidney irritation; [potential occupational carcinogen] | |
|
Target Organs
Liver, blood, kidneys Cancer Site [in animals: liver, lung & bladder tumors] |
|
| See also: INTRODUCTION |